ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Point Therapeutics

Include trials that are no longer recruiting patients.

4 studies were found.
1.RecruitingStudy of Talabostat and Cisplatin in Advanced Melanoma
Conditions: Melanoma; Skin Cancer
2.RecruitingStudy of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer
Condition: Lung Cancer
3.RecruitingStudy of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia
4.RecruitingStudy of Talabostat in Advanced Melanoma
Conditions: Melanoma; Skin Cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act